Stride

UK-based preventative healthtech startup Stride has successfully closed a £4.6 million funding round to accelerate the rollout of its data-driven wellness and early-detection platform. As employers and healthcare systems shift focus from reactive treatment to proactive longevity, Stride's proprietary predictive algorithms are positioned to capture significant market share in the digital health landscape.

Company Profile & Platform Overview

Stride operates at the intersection of consumer health and enterprise wellness, offering a proprietary preventative health platform designed to identify early biomarkers of chronic conditions. By aggregating biometric data from wearables, clinical health records, and lifestyle inputs, Stride's machine learning engine delivers personalized, actionable health interventions directly to end-users while providing aggregated wellness insights to enterprise sponsors.

The company's defensible product moat lies in its proprietary behavioral-change framework and predictive risk models, which demonstrate significantly higher user retention and clinical engagement rates than legacy corporate wellness solutions. Stride monetizes through a B2B2C SaaS model, partnering with self-insured employers and health insurers seeking to mitigate long-term claims costs through proactive preventative care.